Otsuka Chemical Company to acquire American Peptide Company
American Peptide Company's Japanese parent company, Ito Life Sciences, is to be acquired by Otsuka Chemical Company, of Osaka, Japan.
American Peptide Company's Japanese parent company, Ito Life Sciences, is to be acquired by Otsuka Chemical Company, of Osaka, Japan.
Otsuka Chemical Company will become the new owner of American Peptide Company and Ito Life Sciences Shanghai, both subsidiaries of Ito Life Sciences, with effect from 1 September, 2008.
"By operating as an enterprise of Otsuka Chemical Company, we will create new global networking opportunities as well as channel more financial resources to our production and manufacturing facilities," said Takahiro Ogata, president and chief operating officer, American Peptide Company.
American Peptide also expects to enhance its Total Peptide Management programme, a customised service platform that offers a broad array of high-quality peptides, value-added services, and expert consultation to help pharmaceutical and biotech customers properly select peptides and follow correct procedures and compliance guidelines from r&d through scale-up to full manufacturing.
American Peptide Company is also expanding its facilities in Vista and Sunnyvale, California to accommodate large-scale peptide production at the kilogram scale.